SERIOUS ADVERSE EVENTS MAY OCCUR IN 1% OF COVAXIN RECIPIENTS
Why in the news? A study published in Springer Nature highlights that adolescent girls and individuals with co-morbidities are at increased risk of adverse events after receiving Bharat Biotech’s Covexin (BBV152) vaccine. Nearly one-third of participants in the observational study reported adverse events of special interest (AESI). Conducted by Banaras Hindu University, the study titled …
Read More
